| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.027 | 0.6 |